Wellbutrin (bupropion) causes seizures by overstimulating the brain’s excitatory signaling pathways. At standard doses up to 450 mg per day, the risk is roughly 0.4%, or about 4 in every 1,000 people. That risk jumps nearly tenfold at doses between 450 and 600 mg per day, which is why dose limits exist and why understanding the mechanism matters.
How Bupropion Disrupts the Brain’s Electrical Balance
Your brain maintains a careful balance between excitatory signals (which fire neurons) and inhibitory signals (which calm them down). Bupropion works by blocking the reabsorption of two excitatory brain chemicals: norepinephrine and dopamine. This is what makes it effective for depression and smoking cessation. More norepinephrine and dopamine stay active in the brain, improving mood and reducing cravings.
The problem is that both of these chemicals are stimulatory. When too much accumulates, neurons can start firing in rapid, uncontrolled bursts. That uncontrolled electrical activity is a seizure. Bupropion also acts on nicotinic acetylcholine receptors, another pathway that can influence neuronal excitability. The combined effect of all these mechanisms is that bupropion lowers what’s called the “seizure threshold,” the point at which abnormal electrical activity in the brain tips over into a full seizure. Every person has a seizure threshold; bupropion pushes it lower, making seizures easier to trigger.
Dose Is the Single Biggest Risk Factor
The relationship between bupropion dose and seizure risk is not linear. It’s closer to exponential. At doses up to 450 mg per day, the seizure rate sits at about 0.4%. Between 450 and 600 mg per day, that rate climbs to roughly 4%, a nearly tenfold increase. This is why the FDA sets strict maximum daily doses depending on the formulation:
- Immediate-release tablets: no more than 100 mg three times per day, with doses spaced at least 6 hours apart
- Sustained-release tablets: no more than 200 mg twice per day, at least 8 hours apart
- Extended-release tablets (Wellbutrin XL): no more than 300 mg once per day for depression, or 450 mg for certain brand formulations
The spacing matters as much as the total daily amount. Blood levels of bupropion spike after each dose. If you take doses too close together, those spikes overlap and push brain concentrations into dangerous territory. Extended-release formulations were developed partly to smooth out these peaks and reduce seizure risk compared to the original immediate-release version.
Why Eating Disorders Raise the Risk
Wellbutrin is formally contraindicated in people with a current or past diagnosis of bulimia or anorexia nervosa. The FDA specifically warns against it because a higher incidence of seizures was observed in these patients during clinical use. The likely reasons are physiological: people with eating disorders often have electrolyte imbalances, particularly low levels of sodium, potassium, and magnesium. These minerals are essential for normal electrical signaling in the brain. When they’re depleted, the seizure threshold is already lower before bupropion even enters the picture. Malnutrition, dehydration, and purging behaviors all compound the problem.
Alcohol, Withdrawal, and Seizure Risk
The FDA labeling advises limiting or avoiding alcohol while taking bupropion. The concern isn’t so much about having a drink while on the medication. It’s about what happens when someone who drinks heavily suddenly stops. Alcohol withdrawal is one of the most well-known triggers of seizures, and adding bupropion on top of that creates two independent forces pushing the seizure threshold lower at the same time.
Interestingly, the evidence that alcoholism alone (without acute withdrawal) significantly raises bupropion seizure risk is limited. A history of seizures from any cause does slightly increase the risk, though. If you’ve had alcohol withdrawal seizures in the past, that history itself becomes a risk factor.
Medications That Compound the Problem
Several common medications also lower the seizure threshold, and combining them with bupropion can stack the risk. The most notable ones include:
- Tramadol: a pain reliever that independently carries seizure risk
- Certain antipsychotics: particularly clozapine and chlorpromazine
- Older tricyclic antidepressants: such as clomipramine and desipramine
- Theophylline: used for asthma and lung conditions
- Cyclosporine: an immune-suppressing drug used after organ transplants
- Other newer antidepressants: including desvenlafaxine and trazodone
Stimulants like cocaine also lower the seizure threshold and are particularly dangerous in combination with bupropion. The mechanism is similar: too many excitatory chemicals flooding the brain at once.
Warning Signs of Bupropion Toxicity
Seizures from bupropion can happen without much warning, especially at therapeutic doses. But in cases of overdose or toxicity, the body often sends signals beforehand. These include tremor, agitation, lethargy, and vomiting. A rapid heart rate is another common sign, as the same excitatory chemicals affecting the brain also stimulate the heart.
In severe overdoses, cardiac problems can escalate beyond a fast heartbeat into dangerous rhythm disturbances. New-onset seizures of unknown cause, particularly in someone taking bupropion or with access to it, should raise immediate suspicion of toxicity. This is especially relevant because bupropion has been identified as a drug of misuse: some people crush and snort or inject the tablets, which delivers the full dose all at once and dramatically increases the risk of seizures and cardiac complications.
What Keeps the Risk Low at Normal Doses
For most people taking bupropion as prescribed, the 0.4% seizure rate is comparable to or only slightly higher than many other antidepressants. The key factors that keep risk low are straightforward: staying within the recommended dose, spacing doses properly, avoiding abrupt alcohol withdrawal while on the medication, and making sure your prescriber knows about any other medications you take that could lower the seizure threshold.
People with a personal history of seizures, head trauma, or brain tumors are generally at higher baseline risk. The same applies to anyone with conditions that can disrupt electrolytes, including kidney disease, severe liver disease, and eating disorders. In these cases, the decision to use bupropion involves weighing its antidepressant benefits against a seizure risk that starts from a higher baseline than average.